Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 8 studies | 34% ± 15% | |
cardiac muscle cell | 6 studies | 69% ± 19% | |
GABAergic neuron | 4 studies | 26% ± 9% | |
extravillous trophoblast | 3 studies | 54% ± 17% | |
ciliated cell | 3 studies | 47% ± 6% | |
retinal pigment epithelial cell | 3 studies | 40% ± 33% | |
goblet cell | 3 studies | 27% ± 12% | |
transit amplifying cell | 3 studies | 18% ± 2% | |
interneuron | 3 studies | 41% ± 15% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
heart | 4 studies | 32% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
stomach | 97% | 1400.97 | 349 / 359 | 98% | 48.98 | 279 / 286 |
ovary | 94% | 2540.48 | 170 / 180 | 100% | 39.04 | 430 / 430 |
pancreas | 99% | 995.42 | 326 / 328 | 94% | 20.86 | 168 / 178 |
prostate | 97% | 1372.20 | 237 / 245 | 90% | 12.60 | 453 / 502 |
breast | 93% | 1250.67 | 426 / 459 | 82% | 13.87 | 914 / 1118 |
liver | 100% | 1362.86 | 225 / 226 | 72% | 9.72 | 293 / 406 |
intestine | 60% | 2251.02 | 575 / 966 | 99% | 56.62 | 521 / 527 |
kidney | 83% | 434.72 | 74 / 89 | 60% | 6.69 | 544 / 901 |
esophagus | 38% | 413.55 | 552 / 1445 | 91% | 36.58 | 166 / 183 |
uterus | 52% | 327.75 | 89 / 170 | 68% | 12.04 | 312 / 459 |
bladder | 33% | 296.10 | 7 / 21 | 78% | 22.25 | 394 / 504 |
lung | 36% | 213.42 | 209 / 578 | 68% | 16.36 | 780 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.52 | 1 / 1 |
heart | 99% | 13040.15 | 853 / 861 | 0% | 0 | 0 / 0 |
muscle | 89% | 685.95 | 718 / 803 | 0% | 0 | 0 / 0 |
adipose | 80% | 903.65 | 964 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 14.80 | 33 / 45 |
skin | 57% | 379.98 | 1035 / 1809 | 3% | 0.33 | 12 / 472 |
brain | 42% | 228.17 | 1100 / 2642 | 4% | 0.42 | 27 / 705 |
adrenal gland | 8% | 102.40 | 20 / 258 | 32% | 3.57 | 73 / 230 |
spleen | 34% | 153.41 | 83 / 241 | 0% | 0 | 0 / 0 |
thymus | 6% | 27.24 | 36 / 653 | 27% | 3.39 | 162 / 605 |
blood vessel | 17% | 143.52 | 228 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 8% | 55.58 | 78 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0048496 | Biological process | maintenance of animal organ identity |
GO_0072659 | Biological process | protein localization to plasma membrane |
GO_0099017 | Biological process | maintenance of protein localization at cell tip |
GO_0086002 | Biological process | cardiac muscle cell action potential involved in contraction |
GO_0007507 | Biological process | heart development |
GO_0086064 | Biological process | cell communication by electrical coupling involved in cardiac conduction |
GO_0086005 | Biological process | ventricular cardiac muscle cell action potential |
GO_0010810 | Biological process | regulation of cell-substrate adhesion |
GO_0086019 | Biological process | cell-cell signaling involved in cardiac conduction |
GO_0055010 | Biological process | ventricular cardiac muscle tissue morphogenesis |
GO_1900024 | Biological process | regulation of substrate adhesion-dependent cell spreading |
GO_0010765 | Biological process | positive regulation of sodium ion transport |
GO_0045110 | Biological process | intermediate filament bundle assembly |
GO_0002934 | Biological process | desmosome organization |
GO_0086091 | Biological process | regulation of heart rate by cardiac conduction |
GO_0002159 | Biological process | desmosome assembly |
GO_0098911 | Biological process | regulation of ventricular cardiac muscle cell action potential |
GO_0098609 | Biological process | cell-cell adhesion |
GO_0086073 | Biological process | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0051286 | Cellular component | cell tip |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005882 | Cellular component | intermediate filament |
GO_0001533 | Cellular component | cornified envelope |
GO_0005911 | Cellular component | cell-cell junction |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0030054 | Cellular component | cell junction |
GO_0030057 | Cellular component | desmosome |
GO_0014704 | Cellular component | intercalated disc |
GO_0005634 | Cellular component | nucleus |
GO_0005080 | Molecular function | protein kinase C binding |
GO_0045294 | Molecular function | alpha-catenin binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0086083 | Molecular function | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication |
GO_0045296 | Molecular function | cadherin binding |
GO_0019215 | Molecular function | intermediate filament binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0017080 | Molecular function | sodium channel regulator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PKP2 |
Protein name | Plakophilin-2 Truncated plakophilin-2 Plakophilin 2 |
Synonyms | |
Description | FUNCTION: Regulates focal adhesion turnover resulting in changes in focal adhesion size, cell adhesion and cell spreading, potentially via transcriptional modulation of beta-integrins . Required to maintain gingival epithelial barrier function . Required for cardiac sodium current propagation and electrical synchrony in cardiac myocytes, via ANK3 stabilization and modulation of SCN5A/Nav1.5 localization to cell-cell junctions (By similarity). Required for the formation of desmosome cell junctions in cardiomyocytes, thereby required for the correct formation of the heart, specifically trabeculation and formation of the atria walls (By similarity). Loss of desmosome cell junctions leads to mis-localization of DSP and DSG2 resulting in disruption of cell-cell adhesion and disordered intermediate filaments (By similarity). Modulates profibrotic gene expression in cardiomyocytes via regulation of DSP expression and subsequent activation of downstream TGFB1 and MAPK14/p38 MAPK signaling (By similarity). Required for mitochondrial function, nuclear envelope integrity and positive regulation of SIRT3 transcription via maintaining DES localization at its nuclear envelope and cell tip anchoring points, and thereby preserving regulation of the transcriptional program . Maintenance of nuclear envelope integrity protects against DNA damage and transcriptional dysregulation of genes, especially those involved in the electron transport chain, thereby preserving mitochondrial function and protecting against superoxide radical anion generation . May play a role in junctional plaques . Involved in the inhibition of viral infection by influenza A viruses (IAV) . Acts as a host restriction factor for IAV viral propagation, potentially via disrupting the interaction of IAV polymerase complex proteins . . |
Accessions | B8QGS9 A0A087WXY2 ENST00000700559.2 Q99959 ENST00000546741.3 ENST00000340811.9 [Q99959-2] A0A8V8TPU9 A0A8V8TQD7 B8QGS8 ENST00000700563.2 ENST00000070846.11 [Q99959-1] |